Molecular methods will hold promise for the detection of fewer numbers of cells than conventional histological examination. The molecular changes in cancer include epigenetic alterations, such as the abnormal methylation of promoter regions of CpG islands. Molecular techniques based on the sensitive detection of abnormal methylation now exist and hold promise as one such molecular method for detection of tumor cells. Breast cancer, like many other malignancies, has recently been shown to have abnormal methylation of many genes, including some tumor suppressor genes. These changes can then serve as the basis for a molecular detection strategy. The management of breast cancer patients can benefit form more accurate methods of determining risk of disease recurrence following surgical resection. While the majority of women with histologically negative lymph nodes will be cured by local therapy alone, approximately, twenty-five to thirty percent of these patients will go on to recur and die of their disease within ten years of the time diagnosis. A molecular means to more accurately predict recurrence in this group would be desirable. Early detection of breast cancer results in improvements in mortality from the detection of early, more readily curable disease. However, 10-15% of breast cancers are not detected by mammography. An improved method of detection might improve the survival of patients whose tumors are not detectable by mammography.
The specific aims are: 1) To develop and optimize tumor specific DNA methylation changes as a molecular marked in breast cancer and validate this approach in the molecular staging of breast cancer. 2) To use the tissues obtained in a prospective ongoing trial of sentinel lymph node biopsy technology to subdivide the node negative group of patients into group of patients into groups with differing prognoses based on molecular evidence of methylated alleles representing nodal metastasis. 3) To examine the feasibility and utility of the detection of methylated alleles in nipple aspirate fluids (NAF) and ductal lavage (DL) for the early detection of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA088843-01
Application #
6402355
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2000-09-30
Project End
2005-09-29
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Lo, Pang-Kuo (2018) FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells. Trends Diabetes Metab 1:
Cravero, Karen; Medford, Arielle; Pallavajjala, Aparna et al. (2018) Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity. Pract Lab Med 12:e00108
Connolly, Roisin M; Fackler, Mary Jo; Zhang, Zhe et al. (2018) Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Res Treat 167:107-116
Connolly, Roisin M; Li, Huili; Jankowitz, Rachel C et al. (2017) Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. Clin Cancer Res 23:2691-2701
Lo, Pang-Kuo (2017) The controversial role of forkhead box F2 (FOXF2) transcription factor in breast cancer. PRAS Open 1:
Haffner, Michael C; Esopi, David M; Chaux, Alcides et al. (2017) AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination. Nat Commun 8:142
Sunay, Melek M E; Foote, Jeremy B; Leatherman, James M et al. (2017) Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. Int Immunopharmacol 46:112-123
Parsons, Heather A; Beaver, Julia A; Cimino-Mathews, Ashley et al. (2017) Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer. Clin Cancer Res 23:379-386
Cidado, Justin; Wong, Hong Yuen; Rosen, D Marc et al. (2016) Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget 7:6281-93
Lo, Pang-Kuo; Lee, Ji Shin; Liang, Xiaohui et al. (2016) The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression. Cell Signal 28:1502-19

Showing the most recent 10 out of 282 publications